Class information for:
Level 1: P53//AREA BIOPATOL//BCL 2

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
13947 803 39.2 87%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
304 3       P53//RETINOBLASTOMA//MDM2 40663
936 2             P53//MDM2//P73 10991
13947 1                   P53//AREA BIOPATOL//BCL 2 803

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 P53 authKW 112126 29% 1% 231
2 AREA BIOPATOL address 76050 0% 100% 2
3 BCL 2 authKW 65188 14% 2% 113
4 C ERBB 2 authKW 61285 4% 5% 33
5 P53 PROTEIN authKW 54351 4% 5% 30
6 PROPEDEUT SURG CLIN 2 address 50699 0% 67% 2
7 BREAST CANCER authKW 49803 33% 0% 269
8 C ERB B 2 authKW 47194 1% 21% 6
9 BREAST CARCINOMA authKW 45544 7% 2% 59
10 3 GERANYL PHLOROACETOPHENONE authKW 38025 0% 100% 1

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 12810 65% 0% 518
2 Pathology 2344 16% 0% 126
3 Cell Biology 225 10% 0% 84
4 Medical Laboratory Technology 220 3% 0% 24
5 Medicine, Research & Experimental 40 4% 0% 31
6 Obstetrics & Gynecology 36 3% 0% 23
7 Medicine, General & Internal 12 4% 0% 29
8 Genetics & Heredity 11 3% 0% 25
9 Anatomy & Morphology 8 1% 0% 5
10 Biochemistry & Molecular Biology 7 8% 0% 62

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AREA BIOPATOL 76050 0% 100% 2
2 PROPEDEUT SURG CLIN 2 50699 0% 67% 2
3 ANATOMOPATHOL ONCOL RADIOTHER Y 38025 0% 100% 1
4 BAYLOR METHODIST BREAST 38025 0% 100% 1
5 BIOCHEM INSERMCNRSUMR 944 7212 38025 0% 100% 1
6 BIOSTAT UNIT COMPREHENS CANC 38025 0% 100% 1
7 BREAST CANC SHANGHAI ONCOL BREA 38025 0% 100% 1
8 CANC UNIT CLIN BIOCHEM 38025 0% 100% 1
9 CANC WELF HOME 38025 0% 100% 1
10 CELLULAR PATHOL QUEENS MED 38025 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BREAST CANCER RESEARCH AND TREATMENT 6035 4% 0% 34
2 ANTICANCER RESEARCH 2536 4% 0% 36
3 JOURNAL OF BREAST CANCER 2411 1% 1% 6
4 DIAGNOSTIC MOLECULAR PATHOLOGY 2375 1% 1% 7
5 VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY 2271 0% 1% 4
6 INTERNATIONAL JOURNAL OF CANCER 2137 4% 0% 34
7 BRITISH JOURNAL OF CANCER 2134 4% 0% 32
8 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 2061 1% 1% 7
9 CLINICAL CANCER RESEARCH 1696 3% 0% 26
10 BREAST 1555 1% 0% 10

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 P53 112126 29% 1% 231 Search P53 Search P53
2 BCL 2 65188 14% 2% 113 Search BCL+2 Search BCL+2
3 C ERBB 2 61285 4% 5% 33 Search C+ERBB+2 Search C+ERBB+2
4 P53 PROTEIN 54351 4% 5% 30 Search P53+PROTEIN Search P53+PROTEIN
5 BREAST CANCER 49803 33% 0% 269 Search BREAST+CANCER Search BREAST+CANCER
6 C ERB B 2 47194 1% 21% 6 Search C+ERB+B+2 Search C+ERB+B+2
7 BREAST CARCINOMA 45544 7% 2% 59 Search BREAST+CARCINOMA Search BREAST+CARCINOMA
8 3 GERANYL PHLOROACETOPHENONE 38025 0% 100% 1 Search 3+GERANYL+PHLOROACETOPHENONE Search 3+GERANYL+PHLOROACETOPHENONE
9 ALPHA CATALYTIC SUBUNIT OF PHOSPHOINOSITOL 3 KINASE 38025 0% 100% 1 Search ALPHA+CATALYTIC+SUBUNIT+OF+PHOSPHOINOSITOL+3+KINASE Search ALPHA+CATALYTIC+SUBUNIT+OF+PHOSPHOINOSITOL+3+KINASE
10 ANTHRACYCLIN CHEMOTHERAPY 38025 0% 100% 1 Search ANTHRACYCLIN+CHEMOTHERAPY Search ANTHRACYCLIN+CHEMOTHERAPY

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 SIRVENT, JJ , AGUILAR, MC , OLONA, M , PELEGRI, A , BLAZQUEZ, S , GUTIERREZ, C , (2004) PROGNOSTIC VALUE OF APOPTOSIS IN BREAST CANCER (PT1-PT2). A TUNEL, P53, BCL-2, BAG-1 AND BAX IMMUNOHISTOCHEMICAL STUDY.HISTOLOGY AND HISTOPATHOLOGY. VOL. 19. ISSUE 3. P. 759-770 52 73% 24
2 VAGUNDA, V , SMARDOVA, J , VAGUNDOVA, M , JANDAKOVA, E , ZALOUDIK, J , KOUKALOVA, H , (2003) CORRELATIONS OF BREAST CARCINOMA BIOMARKERS AND P53 TESTED BY FASAY AND IMMUNOHISTOCHEMISTRY.PATHOLOGY RESEARCH AND PRACTICE. VOL. 199. ISSUE 12. P. 795-801 51 75% 5
3 PHAROAH, PDP , DAY, NE , CALDAS, C , (1999) SOMATIC MUTATIONS IN THE P53 GENE AND PROGNOSIS IN BREAST CANCER: A META-ANALYSIS.BRITISH JOURNAL OF CANCER. VOL. 80. ISSUE 12. P. 1968-1973 31 94% 181
4 BORRESEN-DALE, AL , (2003) TP53 AND BREAST CANCER.HUMAN MUTATION. VOL. 21. ISSUE 3. P. 292-300 40 62% 164
5 ELLEDGE, RM , ALLRED, DC , (1998) PROGNOSTIC AND PREDICTIVE VALUE OF P53 AND P21 IN BREAST CANCER.BREAST CANCER RESEARCH AND TREATMENT. VOL. 52. ISSUE 1-3. P. 79-98 54 50% 100
6 MALAMOU-MITSI, V , GOGAS, H , DAFNI, U , BOURLI, A , FILLIPIDIS, T , SOTIROPOULOU, M , VLACHODIMITROPOULOS, D , PAPADOPOULOS, S , TZAIDA, O , KAFIRI, G , ET AL (2006) EVALUATION OF THE PROGNOSTIC AND PREDICTIVE VALUE OF P53 AND BCL-2 IN BREAST CANCER PATIENTS PARTICIPATING IN A RANDOMIZED STUDY WITH DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY.ANNALS OF ONCOLOGY. VOL. 17. ISSUE 10. P. 1504-1511 28 74% 26
7 KYNDI, M , SORENSEN, FB , KNUDSEN, H , ALSNER, J , OVERGAARD, M , NIELSEN, HM , OVERGAARD, J , (2008) IMPACT OF BCL2 AND P53 ON POSTMASTECTOMY RADIOTHERAPY RESPONSE IN HIGH-RISK BREAST CANCER. A SUBGROUP ANALYSIS OF DBCG82 B&C.ACTA ONCOLOGICA. VOL. 47. ISSUE 4. P. 608-617 31 65% 10
8 ROLLAND, P , SPENDLOVE, I , MADJID, Z , RAKHA, EA , PATEL, P , ELJIS, IO , DURRANT, L , (2007) THE P53 POSITIVE BCL-2 NEGATIVE PHENOTYPE IS AN INDEPENDENT MARKER OF PROGNOSIS IN BREAST CANCER.INTERNATIONAL JOURNAL OF CANCER. VOL. 120. ISSUE 6. P. 1311-1317 29 63% 21
9 ERMIAH, E , BUHMEIDA, A , KHALED, B , ABDALLA, F , SALEM, N , PYRHONEN, S , COLLAN, Y , (2013) PROGNOSTIC VALUE OF BCL-2 EXPRESSION AMONG WOMEN WITH BREAST CANCER IN LIBYA.TUMOR BIOLOGY. VOL. 34. ISSUE 3. P. 1569-1578 25 60% 4
10 LINJAWI, A , KONTOGIANNEA, M , HALWANI, F , EDWARDES, M , METERISSIAN, S , (2004) PROGNOSTIC SIGNIFICANCE OF P53, BCL-2, AND BAX EXPRESSION IN EARLY BREAST CANCER.JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS. VOL. 198. ISSUE 1. P. 83-90 23 77% 45

Classes with closest relation at Level 1


Rank Class id link
1 1581 P53//P53 GENE//ONCOGENE
2 27700 JOINT SERV BIOMARKER EVALUAT ONCOL//KI67 SCORE//LOCDIR
3 37421 BCL2L12//BCL2L12A//BRAIN TUMOR GENET MED
4 5180 C ERBB 2//HER 2 NEU//P185
5 12433 EI24//CLIN BREAST CARE PROJECT//LOSS OF HETEROZYGOSITY
6 24042 FUSED TOES HOMOLOG//PAN RAS//A RADIATION DOSE OF 27 GY
7 19375 OBLIMERSEN//G3139//ANTISENSE BCL 2
8 8010 MUTANT P53//PRIMA 1//CP 31398
9 853 TRIPLE NEGATIVE BREAST CANCER//TRIPLE NEGATIVE//ONCOTYPE DX
10 19114 LI FRAUMENI SYNDROME//LI FRAUMENI//GERMLINE TP53 MUTATION

Go to start page